Mand, Matthias, Holthaus, Michelle
ORCID: 0000-0002-6207-1141, Lieder, Helmut R.
ORCID: 0000-0003-2237-9050, Kleinbongard, Petra
ORCID: 0000-0003-3576-3772, Conradi, Lenard, Wahlers, Thorsten
ORCID: 0000-0002-8437-4119, Paunel-Görgülü, Adnana
ORCID: 0000-0001-6467-3544 and Simon,, Michel
(2025).
Peptidylarginine deiminase 4 deficiency alleviates hypoxia/reoxygenation-induced cardiomyocyte injury.
PLOS One, 20 (9).
pp. 1-18.
PLoS Public Library of Science.
ISSN 1932-6203
|
PDF
journal.pone.0330864.pdf Bereitstellung unter der CC-Lizenz: Creative Commons Attribution. Download (1MB) |
Abstract
[Artikel-Nr.: e0330864] Background: Cardiac ischemia reperfusion (I/R) injury is a serious consequence of reperfusion therapy for myocardial infarction (MI). Peptidylarginine deiminase 4 (PAD4) is a calcium-dependent enzyme that catalyzes the citrullination of proteins. In previous studies, PAD4 inhibition protected distinct organs from I/R injury by preventing the formation of neutrophil extracellular traps (NETs) and attenuating inflammatory responses. Here, we hypothesized that cardiomyocyte PAD4 expression may play a role in acute I/R injury. Methods: Infarct size was determined in isolated pressure constant-perfused hearts from WT and PAD4-deficient (PAD4 -/- ) mice. Additionally, extracellular reactive oxygen species (ROS) and cell viability were quantified in freshly isolated adult cardiomyocytes exposed to hypoxia followed by reoxygenation (H/R). Resistance to oxidative stress was proven in both genotypes by treatment of neonatal cardiomyocytes with hydrogen peroxide. Moreover, intracellular ROS formation, ATP production, mitochondrial membrane polarisation, caspase-3 activation, and cell viability were quantified after hypoxia followed by 4 h and 20 h of reoxygenation, respectively. The PAD4-specific inhibitor GSK484 was added before H/R or at reperfusion in certain experiments. Results: Infarct size was smaller in PAD4 -/- hearts following I/R when compared to the WT. Similarly, the viability of adult and neonatal PAD4 -/- cardiomyocytes was better preserved after H/R, accompanied by reduced ROS formation. PAD4 deficiency maintained mitochondrial integrity and protected neonatal cardiomyocytes against apoptosis. However, these cells did not exhibit resistance to hydrogen peroxide-induced cell death, indicating an unaltered antioxidative state. Whereas pharmacological PAD4 inhibition by GSK484 before H/R sustained intracellular ATP levels in WT cardiomyocytes, administration of GSK484 at reoxygenation did not. However, GSK484 significantly improved cardiomyocyte metabolic activity, regardless of the time of administration. Conclusions: Our study is the first to demonstrate that PAD4 expression in cardiomyocytes contributes to H/R injury independent of systemic immune responses and NETs. Consequently, PAD4 may serve as a therapeutic target to alleviate I/R injury.
| Item Type: | Article |
| Creators: | Creators Email ORCID ORCID Put Code Mand, Matthias UNSPECIFIED UNSPECIFIED UNSPECIFIED Conradi, Lenard UNSPECIFIED UNSPECIFIED UNSPECIFIED Simon,, Michel UNSPECIFIED UNSPECIFIED UNSPECIFIED |
| URN: | urn:nbn:de:hbz:38-811518 |
| Identification Number: | 10.1371/journal.pone.0330864 |
| Journal or Publication Title: | PLOS One |
| Volume: | 20 |
| Number: | 9 |
| Page Range: | pp. 1-18 |
| Number of Pages: | 18 |
| Date: | 10 September 2025 |
| Publisher: | PLoS Public Library of Science |
| ISSN: | 1932-6203 |
| Language: | English |
| Faculty: | Faculty of Medicine |
| Divisions: | Faculty of Medicine > Chirurgie > Klinik und Poliklinik für Herzchirurgie |
| Subjects: | Medical sciences Medicine |
| ['eprint_fieldname_oa_funders' not defined]: | Publikationsfonds UzK |
| Refereed: | Yes |
| URI: | http://kups.ub.uni-koeln.de/id/eprint/81151 |
Downloads
Downloads per month over past year
Altmetric
Export
Actions (login required)
![]() |
View Item |
https://orcid.org/0000-0002-6207-1141